Cascade Health Solutions v. PeaceHealth

Court of Appeals for the Ninth Circuit
515 F.3d 883 (2008)
ELI5:

Rule of Law:

To establish that a bundled discount constitutes exclusionary conduct under § 2 of the Sherman Act, a plaintiff must prove that after allocating the full discount to the competitive product, the defendant sold the competitive product below its average variable cost.


Facts:

  • McKenzie-Willamette Hospital ('McKenzie') and PeaceHealth were the only two providers of hospital care in Lane County, Oregon.
  • PeaceHealth operated multiple hospitals providing primary, secondary, and tertiary care, holding a market share of approximately 75% for primary/secondary services and over 90% for tertiary services, which McKenzie did not offer.
  • McKenzie operated one hospital that offered only primary and secondary acute care services.
  • PeaceHealth offered bundled discounts to health insurers, conditioning lower reimbursement rates on the insurer making PeaceHealth its sole preferred provider for all three levels of care (primary, secondary, and tertiary).
  • When insurer Regence considered adding McKenzie as a provider for primary/secondary services, PeaceHealth offered a substantially worse reimbursement rate (90%) than the rate offered if PeaceHealth remained the sole provider (85%).
  • As a result of PeaceHealth's pricing structure, Regence declined to add McKenzie to its preferred provider plan.
  • Similarly, after insurer Providence added McKenzie as a preferred provider, PeaceHealth increased its reimbursement rate charged to Providence from 90% to 93%, making it more expensive for the insurer to include McKenzie.

Procedural Posture:

  • McKenzie-Willamette Hospital ('McKenzie') sued PeaceHealth in the United States District Court for the District of Oregon, alleging federal antitrust and state law violations.
  • Prior to trial, the district court granted summary judgment in favor of PeaceHealth on McKenzie's tying claim.
  • The remaining claims proceeded to a jury trial.
  • The jury found for PeaceHealth on the monopolization and conspiracy to monopolize claims but found for McKenzie on the attempted monopolization, price discrimination, and tortious interference claims.
  • The jury awarded McKenzie $5.4 million in damages, which the district court trebled to $16.2 million for the attempted monopolization claim.
  • The district court also awarded McKenzie attorneys' fees and costs.
  • PeaceHealth appealed the judgment against it to the U.S. Court of Appeals for the Ninth Circuit, and McKenzie cross-appealed the summary judgment ruling on its tying claim.

Locked

Premium Content

Subscribe to Lexplug to view the complete brief

You're viewing a preview with Rule of Law, Facts, and Procedural Posture

Issue:

Must a plaintiff prove that a defendant's bundled discount resulted in below-cost pricing, after allocating the full discount to the competitive product, to establish the exclusionary conduct element of an attempted monopolization claim under § 2 of the Sherman Act?


Opinions:

Majority - Gould

Yes. A plaintiff must prove below-cost pricing under a specific cost-allocation standard to show that a bundled discount is exclusionary under § 2 of the Sherman Act. The court adopted a new test, holding that a bundled discount is only exclusionary if, after attributing the entire multi-product discount to the competitive product, the resulting price of that product is below the defendant's average variable cost of producing it. The court reasoned that bundled discounts are pervasive and often pro-competitive, and antitrust laws should not be used to chill legitimate price competition that benefits consumers. It explicitly rejected the Third Circuit's standard in LePage's Inc. v. 3M, finding it vague and capable of protecting less-efficient competitors at the expense of consumer welfare. The Supreme Court's jurisprudence, particularly in Brooke Group, strongly favors a cost-based standard, as above-cost pricing is generally considered competition on the merits. The adopted 'discount attribution' test protects competition by condemning only those discounts that would exclude a hypothetical, equally efficient rival, while providing a clear safe harbor for businesses. Because the district court's jury instruction was based on the rejected LePage's standard, it was an error of law, and the verdict for attempted monopolization was vacated.



Analysis:

This case creates a circuit split with the Third Circuit's decision in LePage's Inc. v. 3M, establishing a more defense-friendly, cost-based safe harbor for bundled discounting in the Ninth Circuit. By rejecting the less-defined standard from LePage's, the court provides greater certainty for dominant firms that wish to use this common pricing strategy. The decision aligns the legal analysis of multi-product discounts more closely with the Supreme Court's framework for single-product predatory pricing, prioritizing price competition and consumer welfare over the protection of individual competitors who may be less efficient.

G

Gunnerbot

AI-powered case assistant

Loaded: Cascade Health Solutions v. PeaceHealth (2008)

Try: "What was the holding?" or "Explain the dissent"